New COVID Variant BA.3.2 Spreading Across the U.S.: What You Necessitate to Know
A mutated strain of the COVID-19 virus, first detected in the U.S. In a traveler arriving at San Francisco International Airport (SFO), is increasingly appearing across the country. The variant, known as BA.3.2, contains genetic changes that could help it evade immunity from prior infection or vaccination.
What is the BA.3.2 Variant?
The BA.3.2 variant was first identified in a respiratory sample collected in South Africa in November 2024. As of February 11, 2026, it had been reported in 23 countries, according to a recent report from the U.S. Centers for Disease Control and Prevention (CDC). The strain is genetically distinct from JN.1 lineages that have been circulating since January 2024.
BA.3.2 has roughly 70 to 75 substitutions and deletions in the gene sequence of its spike protein compared to the JN.1 variant. These mutations in the spike protein have the potential to reduce protection from previous infection or vaccination.
How Widespread is BA.3.2 in the U.S.?
The CDC’s Traveler-Based Genomic Surveillance program first identified BA.3.2 in the U.S. In June 2025, in a traveler arriving from the Netherlands. As of February 11, 2026, the variant had been detected in nasal swabs from four travelers, clinical samples from five patients, three airplane wastewater samples, and 132 wastewater samples from 25 U.S. States. Wastewater data currently shows relatively low levels of the virus in the Bay Area.
Did you know? Genomic surveillance, including wastewater monitoring, plays a crucial role in tracking the evolution of SARS-CoV-2 and identifying potential public health risks.
What Do Experts Say?
Dr. William Schaffner, an infectious disease expert at Vanderbilt University Medical Center, described the variant as “substantially different” from previous strains. However, he noted that it’s currently unclear if BA.3.2 will cause more severe illness. Lab studies suggest it doesn’t infect lung cells as easily as other strains.
Dr. Monica Gandhi, an infectious disease expert at UC San Francisco, suggests the region could see a “spring surge” of COVID-19. She has observed more patients testing positive during routine screening at San Francisco General.
Will Vaccines Still Perform?
Experts emphasize that even with immune escape mutations, COVID-19 vaccines will likely continue to provide protection against severe illness. While antibodies from previous vaccines may not be as effective against BA.3.2, T cells and B cells – also generated by vaccination – should still offer significant protection.
Pro Tip: Individuals at high risk for severe COVID-19 symptoms, such as older adults, should consider receiving a booster shot to enhance their immune protection.
The Importance of Continued Surveillance
The CDC report highlights the importance of ongoing genomic surveillance to track SARS-CoV-2 evolution and assess its potential impact on public health. As one expert put it, “What’s over there can be over here in 24 hours,” underscoring the need for a global perspective on disease monitoring.
Frequently Asked Questions (FAQ)
Q: Is the BA.3.2 variant more dangerous than previous strains?
A: It’s currently unclear. While it has mutations that could help it evade immunity, lab studies suggest it may not infect lung cells as easily.
Q: Will my COVID-19 vaccine protect me against BA.3.2?
A: Vaccines are expected to continue providing protection against severe illness, even with immune escape mutations. Booster shots are recommended for high-risk individuals.
Q: Where can I find more information about COVID-19 variants?
A: You can find the latest information from the CDC’s Morbidity and Mortality Weekly Report.
Stay informed and prioritize your health. Continue to monitor updates from public health officials and consider taking appropriate precautions to protect yourself and others.
